Jushi Holdings (JUSHF) Non Operating Income (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Non Operating Income came in at -$12.7 million in Q1 2026, down 106.18% year-on-year from $205.7 million in Q1 2025, and down 39.93% on a QoQ basis from -$9.1 million in Q4 2025.

Jushi Holdings (JUSHF) Non Operating Income (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Non Operating Income data on file, last reported at -$12.7 million in Q1 2026.

  • On a quarterly basis, Non Operating Income fell 106.18% year-over-year to -$12.7 million in Q1 2026; TTM through Mar 2026 was -$45.0 million, a 82.69% decrease from a year earlier, with the FY2025 full-year figure at -$38.5 million, down 37.29% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$12.7 million, down from -$9.1 million in the prior quarter.
  • Over the last five years, Non Operating Income for JUSHF reached as high as $31.9 million in Q2 2022 and fell as low as -$17.2 million in Q3 2025.
  • Historically, Non Operating Income has averaged -$5.3 million across 5 years, with a median of -$9.1 million in 2024.
  • Across the five-year window, Non Operating Income soared 131.78% in 2022 and slumped 69784.62% in 2025, its largest moves.
  • Year by year, Non Operating Income stood at -$11.4 million in 2022, then jumped by 75.27% to -$2.8 million in 2023, then surged by 99.54% to -$13000.0 in 2024, then slumped by 69784.62% to -$9.1 million in 2025, then tumbled by 39.93% to -$12.7 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Income figures were -$12.7 million in Q1 2026, -$9.1 million in Q4 2025, and -$17.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn -12.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.71 Mn
Dec 31, 2025 -9.09 Mn
Sep 30, 2025 -17.20 Mn
Jun 30, 2025 -6.01 Mn
Mar 31, 2025 -6.17 Mn
Dec 31, 2024 -13,000.00
Sep 30, 2024 -9.38 Mn
Jun 30, 2024 -9.07 Mn
Mar 31, 2024 -9.54 Mn
Dec 31, 2023 -2.82 Mn
Sep 30, 2023 -15.44 Mn
Jun 30, 2023 -9.79 Mn
Mar 31, 2023 219,000.00
Dec 31, 2022 -11.42 Mn
Sep 30, 2022 -7.05 Mn
Jun 30, 2022 31.85 Mn
Mar 31, 2022 3.49 Mn
Dec 31, 2021 40.86 Mn
Sep 30, 2021 47.84 Mn
Jun 30, 2021 13.74 Mn